Journal of the Bahrain Medical Society
Year 2024, Volume 36, Issue 4, Pages 1-12
https://doi.org/10.26715/jbms.36_4_2 Dr. H. H. Alkaabi
*Corresponding author:
Dr. H. H. Alkaabi, M.D, Arab board of family medicine, Irish board of family medicine, Consultant of family medicine in primary care of Royal Medical Service; E-Mail: drhessaalkaabi@gmail.com
Received date: June 28, 2024; Accepted date: November 12, 2024; Published date: December 31, 2024
For appendix, tables and figures (if any), please refer to PDF.
Abstract
Background: This study evaluates screening and management of renal impairment in adults with type 2 diabetes at the Royal Medical Services in Bahrain. Type 2 diabetes is a significant risk factor for chronic kidney disease, underscoring the importance of early identification and proper management in primary healthcare.
Methods: This retrospective study analyzed data from primary healthcare clinics' electronic medical records of 292 patients with type 2 diabetes. The study included 160 males (54.8%) and 132 females (45.2%), ranging from 32 to 94 years old. It focused on sociodemographic details, diabetic history, albuminuria screening, eGFR, and medication management for those with renal impairment.
Results:Among 292 patients, 57.9% had detectable albumin creatinine levels. In the albuminuria group, 31.5% were morbidly obese, while 27.3% were moderately obese. For patients with albuminuria, 39% had good HbA1c control (<7%), with a mean HbA1c of 7.5 ± 1.4. Both groups had a high prevalence of stage 2 hypertension cases. 9.4% of the albuminuria group were referred to nephrology for evaluation. Re-testing rates were 85.8% for albuminuria patients and 87.7% for non-albuminuria patients.
Discussion: Addressing compliance issues with regular urinary monitoring is crucial to improving diabetic kidney disease screening. The study underscores connections between albuminuria, obesity, and glycemic control, emphasizing the necessity for more research on renal risk factors for CKD progression. Results show good screening rates for T2DM complications in primary care, with a considerable number of patients having undetected renal issues. Implementing evidence-based strategies and guideline-driven assessments can enhance early T2DM detection and optimize diabetic kidney disorder management in this population.
Conclusion: The study on screening and managing diabetic kidney disease (DKD) in adults with type 2 diabetes. It focuses on early detection, high-risk populations, and intervention to prevent DKD progression. The study emphasizes the role of primary care physicians in identifying and managing DKD in type 2 diabetes patients to ensure effective care and prevent disease advancement.
Keywords: Chronic kidney disease, Type 2 diabetes mellitus, Albumin creatinine levels